The Influence of Anti-ETAR and Anti-CXCR3 Antibody Levels on the Course of Specific Glomerulonephritis Types
<b>Background:</b> Anti-ETAR (endothelin A receptor) antibodies and anti-CXCR3 (C-X-C motif chemokine receptor 3) antibodies are types of non-HLA (human leukocyte antigens) antibodies that could have some influence on the course of glomerulonephritis. The authors aimed to study the influence of these antibodies' levels on the course of specific glomerulonephritis types. <b>Methods:</b> We evaluated the anti-ETAR and anti-CXCR3 antibody levels in the serum of patients with membranous nephropathy (n = 18), focal and segmental glomerulosclerosis (FSGS) (n = 25), systemic lupus erythematosus (n = 17), IgA nephropathy (n = 14), mesangiocapillary glomerulonephritis (n = 6), anti-neutrophil cytoplasmic antibodies (c-ANCA) vasculitis (n = 40), and perinuclear anti-neutrophil cytoplasmic antibodies (p-ANCA) vasculitis (n = 16), and we compared their levels with the control group (n = 22). Next, we observed the patients' clinical parameters (serum creatinine, albumin, total protein) for 2 years and checked the correlation of the clinical course markers with basic receptor antibody level. <b>Results:</b> Our results indicate lower anti-ETAR antibody levels in patients with FSGS and IgA nephropathy compared to the control group. Both types of antibodies correlated with creatinine levels after 2 years of observation in IgA nephropathy. Both types of antibodies seemed to negatively influence the total protein and albumin levels in systemic lupus erythematosus. <b>Conclusions</b>: This prospective observation showed that anti-ETAR and anti-CXCR 3 antibody levels are connected with the course of IgA nephropathy and lupus nephritis.
Authors
- Kai Schulze‐Forster (ORCID: https://orcid.org/0009-0008-7297-8717)
- Jakub Wronowicz (ORCID: https://orcid.org/0000-0002-1454-2068)
- Mirosław Banasik (ORCID: https://orcid.org/0000-0002-0588-1551)
- Andrzej Konieczny (ORCID: https://orcid.org/0000-0002-4966-9771)
- Tomasz Gołębiowski (ORCID: https://orcid.org/0000-0001-5477-2020)
- Karolina Skalec
- Marcelina Żabińska (ORCID: https://orcid.org/0000-0003-1810-3131)
- Krzysztof Kujawa (ORCID: https://orcid.org/0000-0003-2812-4702)
- Maciej Szymczak (ORCID: https://orcid.org/0000-0002-1248-081X)
- Łucja Janek
- Harald Heidecke (ORCID: https://orcid.org/0009-0009-1270-202X)
- Karolina Bukowiec-Marek
Institutions
- Wrocław University of Science and Technology (PL)
- Wroclaw Medical University (PL)
- AGH University of Krakow (PL)
Publication Details
- Journal
- Journal of Clinical Medicine
- Published
- 2024-12-19
- DOI
- https://doi.org/10.3390/jcm13247752
- Citations
- 3
- Primary Topic
- Renal Diseases and Glomerulopathies
- Type
- article
- Field-Weighted Citation Impact
- 1.02
Funders
- Uniwersytet Medyczny im. Piastów Slaskich we Wroclawiu